Eugene P. Brandon PhD

Eugene P. Brandon, Ph.D., is a leading expert in cell therapy, gene therapy, stem cell biotechnology, and translational medicine. Brandon is currently the senior director of strategic relations at ViaCyte, where he has been integral in the development of an innovative stem cell-based product for diabetes. Prior to ViaCyte, he was at Ceregene, pursuing gene therapy for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. Brandon has secured over $60M in research grants for his respective institutions and his scientific work has yielded numerous publications and several patents.

He serves on the communications committee of the Alliance for Regenerative Medicine and is also board chair of the Greater San Diego Chapter, as well as research committee vice chair for the ALS Association. Brandon received his B.S. from Tufts University, earned his PhD in pharmacology and neurobiology at the University of Washington School of Medicine, and did his post-doctoral training at the Salk Institute for Biological Studies. He holds a certificate in biotechnology project management as well.